The process begins by reprogramming fat cells into stem cells. These cells are then used to 3D-print a heart containing chambers, blood vessels, and cardiac muscle — all biologically matched to the patient. Unlike previous lab-grown tissues, this heart contracts in a coordinated way.

Because it’s made entirely from the patient’s own cells, the risk of immune rejection is dramatically reduced — potentially eliminating the need for lifelong immunosuppressive drugs.